Go to content
UR Home

Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease

URN to cite this document:
DOI to cite this document:
Richardson, Paul M. ; Ho, Vincent T. ; Giralt, Sergio ; Arai, Sally ; Mineishi, Shin ; Cutler, C. ; Antin, Joseph H. ; Stavitzski, N. ; Niederwieser, N. ; Holler, Ernst
License: Allianz- bzw. Nationallizenz
PDF - Published Version
Date of publication of this fulltext: 24 Aug 2016 12:12


Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome, is a potentially life-threatening complication of chemotherapeutic conditioning used in preparation for hematopoietic stem-cell transplantation (SCT). VOD may occur in up to 62% of patients undergoing SCT, with onset generally within the first month after SCT. In severe cases, 100-day mortality is in excess of ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons